Jennifer Marvin‐Peek

Current and future therapies for acute myeloblastic leukemia

The management of acute myeloid leukemia (AML) has undergone a remarkable transformation over the past decade, as advances in genomic profiling and drug development have expanded therapeutic options and enabled increasingly personalized treatment approaches. This review summarize...